LONDON, September 20, 2010 /PRNewswire/ -- Three quarters of parents aren't confident about diagnosing illness in their own children, according to results of a new survey released today. Worryingly…

PARIS, September 20, 2010 /PRNewswire/ -- Sanofi-aventis announced today results of two studies presented at the European Association for the Study of Diabetes (EASD) 46th Annual Meeting in…

READING, England, September 20, 2010 /PRNewswire/ -- DediPower Managed Hosting today announced that it is officially ranked as one of the UK's top 50 fastest growing private tech companies and the…

NATICK, Massachusetts, September 20, 2010 /PRNewswire/ -- Boston Scientific Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for its…

PARIS, September 20, 2010 /PRNewswire/ -- Sanofi-aventis announced today the first Phase III results of the GetGoal clinical trial program assessing the efficacy and safety of lixisenatide, a once-…

NEW YORK, September 20, 2010 /PRNewswire/ -- Emmy award-winning actress Claire Danes will join millions of people who've added their thumbprints to an innovative and unique global petition at Grand…

LONDON, September 20, 2010 /PRNewswire/ -- A recent survey conducted by AdvanceNet - http://www.advancenet.co.za - Africa's leading simple CRM (http://www.reallysimplesystems.com/simple_crm.asp)…

HOCHBERG, Germany, September 20, 2010 /PRNewswire/ -- CareFusion , a leading, global medical device company, today announced the commercial release of SentrySuite(TM), the next-generation clinical…

STOCKHOLM, September 20, 2010 /PRNewswire/ -- Bristol-Myers Squibb Company (http://www.bms.com) and AstraZeneca (http://www.astrazeneca-us.com) today announced results from a randomized, double blind…

If we could identify a gene for creativity, let's call it the "creativity gene", you would be hard pressed to find very many people who would consider it a "negative gene" or a hazard to possess or…